BRIEF published on 12/18/2025 at 22:10, 18 hours 53 minutes ago Abivax joins the Nasdaq Biotechnology index Biotechnology Abivax Obefazimod Ulcerative Colitis Nasdaq Biotechnology
BRIEF published on 12/18/2025 at 22:10, 18 hours 53 minutes ago Abivax rejoint l'indice Nasdaq Biotechnology Biotechnologie Abivax Obefazimod Rectocolite Hémorragique Nasdaq Biotechnology
BRIEF published on 12/18/2025 at 22:10, 18 hours 53 minutes ago Abivax intègre l'indice Nasdaq Biotechnology Biotechnologie Abivax Obefazimod Rectocolite Hémorragique Indice Nasdaq Biotechnology
BRIEF published on 12/18/2025 at 22:10, 18 hours 53 minutes ago Abivax Joins Nasdaq Biotechnology Index Biotechnology Abivax Obefazimod Ulcerative Colitis Nasdaq Biotechnology Index
PRESS RELEASE published on 12/18/2025 at 22:05, 18 hours 57 minutes ago Abivax fait son entrée au sein de l'indice Nasdaq Biotechnology Abivax intègre l'Indice Biotechnologie du Nasdaq, témoignant de sa croissance et de ses avancées cliniques. Le NBI suit les performances des sociétés du secteur Biotechnologie Abivax Nasdaq Clinique NBI
PRESS RELEASE published on 12/18/2025 at 22:05, 18 hours 58 minutes ago Abivax fait son entrée au sein de l'indice Nasdaq Biotechnology Abivax intègre l'indice Nasdaq Biotechnology, rejoignant le NBI avec impact le 22 décembre 2025. Un pas significatif pour la société de biotechnologie française Biotechnologie Abivax France Nasdaq Biotechnology Indice
PRESS RELEASE published on 12/18/2025 at 22:05, 18 hours 58 minutes ago Abivax to be Added to Nasdaq Biotechnology Index Abivax to be added to Nasdaq Biotechnology Index, reflecting company's progress in developing therapeutics for chronic inflammatory diseases. Inclusion effective December 22, 2025 Biotechnology Abivax Therapeutics Immune Response Nasdaq Biotechnology Index
BRIEF published on 12/17/2025 at 22:10, 1 day 18 hours ago Abivax : 22 Abstracts sur Obefazimod Présentés à l'ECCO 2026 Abivax Obefazimod Efficacité Fibrose MICI
BRIEF published on 12/17/2025 at 22:10, 1 day 18 hours ago Abivax: 22 Abstracts on Obefazimod Presented at ECCO 2026 Abivax Obefazimod Efficiency Fibrosis IBD
BRIEF published on 12/17/2025 at 22:10, 1 day 18 hours ago Abivax dévoile de nouvelles données sur l'obefazimod à l'ECCO 2026 Abivax Obefazimod Rectocolite Hémorragique ECCO 2026 Antifibrotique
Published on 12/19/2025 at 14:40, 2 hours 23 minutes ago Northern Superior Announces Closing of the Arrangement
Published on 12/19/2025 at 13:30, 3 hours 33 minutes ago Quartz Commences Trading On The OTCQX Best Market Under The Symbol QZMRF
Published on 12/19/2025 at 13:30, 3 hours 33 minutes ago DataMetrex Announces Closing of Yuzu Payment Processing Solution Acquisition
Published on 12/19/2025 at 13:30, 3 hours 33 minutes ago Sterling Metals Provides Year End Update to Stakeholders
Published on 12/19/2025 at 13:05, 3 hours 58 minutes ago Roxmore Resources Begins Trading on the OTCQX Best Market in the United States
Published on 12/19/2025 at 16:51, 12 minutes ago EQS-Adhoc: JENOPTIK AG: Daniela Mattheus becomes new Chairwoman of the Supervisory Board of JENOPTIK AG
Published on 12/19/2025 at 16:30, 33 minutes ago The Platform Group acquires fashion platform 43einhalb
Published on 12/19/2025 at 14:54, 2 hours 8 minutes ago Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc.
Published on 12/19/2025 at 08:30, 8 hours 33 minutes ago Share capital decrease by way of treasury shares cancellation
Published on 12/19/2025 at 08:30, 8 hours 33 minutes ago Réduction du capital par voie d’annulation d’actions propres
Published on 12/19/2025 at 07:00, 10 hours 3 minutes ago EURAZEO ANNONCE AVOIR MENÉ AVEC SUCCÈS UNE TRANSACTION ACCÉLÉRANT SA ROTATION D'ACTIFS
Published on 12/19/2025 at 07:00, 10 hours 3 minutes ago EURAZEO ANNOUNCES A SUCCESSFUL TRANSACTION ACCELERATING ITS ASSET ROTATION
Published on 12/18/2025 at 18:30, 22 hours 33 minutes ago Schneider Electric completes transaction to acquire remaining 35% stake in existing Indian JV
